SUCAMPO PHARMACEUTICALS INC's ticker is SCMP and the CUSIP is 864909106. A total of 125 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 2.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $122,000 | -89.6% | 10,300 | -90.8% | 0.01% | -87.2% |
| Q2 2017 | $1,171,000 | +3.3% | 111,500 | +7.8% | 0.04% | +2.6% |
| Q2 2016 | $1,134,000 | -60.7% | 103,400 | -38.0% | 0.04% | -47.2% |
| Q4 2015 | $2,882,000 | -23.0% | 166,700 | -11.6% | 0.07% | -49.7% |
| Q3 2015 | $3,745,000 | +248.4% | 188,500 | +188.2% | 0.14% | +410.7% |
| Q2 2015 | $1,075,000 | +60.9% | 65,400 | +52.4% | 0.03% | +47.4% |
| Q1 2015 | $668,000 | – | 42,900 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 555,652 | $9,607,000 | 3.06% |
| OBERWEIS ASSET MANAGEMENT INC/ | 96,630 | $1,671,000 | 0.47% |
| JUNCTURE WEALTH STRATEGIES, LLC | 35,281 | $610,000 | 0.46% |
| AWM Investment Company, Inc. | 100,000 | $1,729,000 | 0.34% |
| GLOBEFLEX CAPITAL L P | 65,588 | $1,134,000 | 0.30% |
| NEW AMSTERDAM PARTNERS LLC/NY | 166,479 | $2,878,000 | 0.30% |
| Convergence Investment Partners, LLC | 100,850 | $1,744,000 | 0.20% |
| GSA CAPITAL PARTNERS LLP | 219,881 | $3,802,000 | 0.19% |
| OXFORD ASSET MANAGEMENT LLP | 433,219 | $7,672,000 | 0.18% |
| Zebra Capital Management LLC | 17,720 | $306,000 | 0.17% |